BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34335957)

  • 41. VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation.
    Fantozzi A; Gruber DC; Pisarsky L; Heck C; Kunita A; Yilmaz M; Meyer-Schaller N; Cornille K; Hopfer U; Bentires-Alj M; Christofori G
    Cancer Res; 2014 Mar; 74(5):1566-75. PubMed ID: 24413534
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ZEB1 is neither sufficient nor required for epithelial-mesenchymal transition in LS174T colorectal cancer cells.
    Jägle S; Dertmann A; Schrempp M; Hecht A
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1226-1232. PubMed ID: 27923654
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EMT-associated factors promote invasive properties of uveal melanoma cells.
    Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
    Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epithelial-mesenchymal transition inducer Snail1 and invasive potential of intraductal breast cancer.
    Szynglarewicz B; Kasprzak P; Donizy P; Biecek P; Halon A; Matkowski R
    J Surg Oncol; 2017 Nov; 116(6):696-705. PubMed ID: 28570750
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Slug/Pcad pathway controls epithelial cell dynamics in mammary gland and breast carcinoma.
    Idoux-Gillet Y; Nassour M; Lakis E; Bonini F; Theillet C; Du Manoir S; Savagner P
    Oncogene; 2018 Feb; 37(5):578-588. PubMed ID: 28991231
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes.
    Perdigão-Henriques R; Petrocca F; Altschuler G; Thomas MP; Le MT; Tan SM; Hide W; Lieberman J
    Oncogene; 2016 Jan; 35(2):158-72. PubMed ID: 25798844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. OTUD4 regulates metastasis and chemoresistance in melanoma by stabilizing Snail1.
    Gao Y; Tang J; Ma X; Zhang C; Huang L; Che J; Wen Y; Zhang Y; Zhu Y; Liu T; Zhang H
    J Cell Physiol; 2023 Nov; 238(11):2546-2555. PubMed ID: 37642406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dual role of Snail1 as transcriptional repressor and activator.
    García de Herreros A
    Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189037. PubMed ID: 38043804
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Formation of an invasion-permissive matrix requires TGFβ/SNAIL1-regulated alternative splicing of fibronectin.
    Franco-Valls H; Tusquets-Uxó E; Sala L; Val M; Peña R; Iaconcig A; Villarino Á; Jiménez-Arriola M; Massó P; Trincado JL; Eyras E; Muro AF; Otero J; García de Herreros A; Baulida J
    Breast Cancer Res; 2023 Nov; 25(1):143. PubMed ID: 37964360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
    Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H
    Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Up-regulation of long non-coding RNA XLOC_010235 regulates epithelial-to-mesenchymal transition to promote metastasis by associating with Snail1 in gastric cancer.
    Liu YY; Chen ZH; Peng JJ; Wu JL; Yuan YJ; Zhai ET; Cai SR; He YL; Song W
    Sci Rep; 2017 May; 7(1):2461. PubMed ID: 28550287
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Snail1 suppresses TGF-beta-induced apoptosis and is sufficient to trigger EMT in hepatocytes.
    Franco DL; Mainez J; Vega S; Sancho P; Murillo MM; de Frutos CA; Del Castillo G; López-Blau C; Fabregat I; Nieto MA
    J Cell Sci; 2010 Oct; 123(Pt 20):3467-77. PubMed ID: 20930141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biological Aggressiveness of Subclinical No-Mass Ductal Carcinoma In Situ (DCIS) Can Be Reflected by the Expression Profiles of Epithelial-Mesenchymal Transition Triggers.
    Szynglarewicz B; Kasprzak P; Donizy P; Biecek P; Halon A; Matkowski R
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544617
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The role of protein kinase PAK1 in the regulation of estrogen-independent growth of breast cancer].
    Avilova EA; Andreeva OE; Shatskaia VA; Krasil'nikov MA
    Biomed Khim; 2014; 60(3):322-31. PubMed ID: 25019394
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer.
    Chang CW; Yu JC; Hsieh YH; Yao CC; Chao JI; Chen PM; Hsieh HY; Hsiung CN; Chu HW; Shen CY; Cheng CW
    Oncotarget; 2016 Mar; 7(13):16462-78. PubMed ID: 26918943
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
    Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Involvement of epithelial-mesenchymal transition-inducing transcription factors in the mechanism of Helicobacter pylori-induced fibroblasts activation.
    Krzysiek-Maczka G; Targosz A; Szczyrk U; Strzalka M; Brzozowski T; Ptak-Belowska A
    J Physiol Pharmacol; 2019 Oct; 70(5):. PubMed ID: 31889044
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genome-wide mapping of DNA-binding sites identifies stemness-related genes as directly repressed targets of SNAIL1 in colorectal cancer cells.
    Beyes S; Andrieux G; Schrempp M; Aicher D; Wenzel J; Antón-García P; Boerries M; Hecht A
    Oncogene; 2019 Oct; 38(40):6647-6661. PubMed ID: 31391555
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells.
    Plummer PN; Freeman R; Taft RJ; Vider J; Sax M; Umer BA; Gao D; Johns C; Mattick JS; Wilton SD; Ferro V; McMillan NA; Swarbrick A; Mittal V; Mellick AS
    Cancer Res; 2013 Jan; 73(1):341-52. PubMed ID: 22836757
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
    Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
    Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.